HNWAG
IMRX icon

High Net Worth Advisory Group’s Immuneering IMRX Stock Holding History

High Net Worth Advisory Group’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-800
Closed -$5K – 692
2022
Q1 		$5K Buy
+800
New +$7.68K ﹤0.01% 592

Other funds holding IMRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BSW
Buckingham Strategic Wealth Clayton, Missouri $9.66B AUM 15.76% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

High Net Worth Advisory Group's IMRX Position: Q2 2022 in Review

High Net Worth Advisory Group sold out of Immuneering (IMRX) in Q2 2022, closing a stake of 800 shares — an estimated $5K sold.

High Net Worth Advisory Group first reported a position in IMRX in Q1 2022 and held it in 1 quarter. The position peaked at $5K in Q1 2022. 37 funds tracked by Wall St. Rank hold IMRX as of Q2 2022.

  • High Net Worth Advisory Group reported no remaining Immuneering position as of Q2 2022 after selling out during the quarter.
  • High Net Worth Advisory Group sold 800 Immuneering shares in Q2 2022, an estimated $5K.
  • High Net Worth Advisory Group first reported a position in Immuneering in Q1 2022 and held it in 1 quarter.
  • High Net Worth Advisory Group's Immuneering position peaked at $5K in Q1 2022.
  • 37 funds tracked by Wall St. Rank held Immuneering as of Q2 2022.

Based on High Net Worth Advisory Group's 13F filing for Q2 2022, filed 10 Aug 2022.